Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Cancer Discovery|August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified CancersGiulia Montuori, Fengyu Tu, Di Qin, et al.
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Cell Stem Cell|June 18, 2019
Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma TumorigenesisMiller Huang, Jignesh Tailor, Qiqi Zhen, et al.
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
Acta Neuropathologica|July 23, 2017
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomePooja Panwalkar, Jonathan Clark, Vijay Ramaswamy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 RearrangementsAshutosh Tiwari, Utkarsha Paithane, Jordan Friedlein, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Research Square|July 3, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade GliomaCarl Koschmann, Kallen Schwark, Kelsey Wink, et al.
Acta Neuropathologica|June 18, 2018
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomasKristian W Pajtler, Ji Wen, Martin Sill, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Pageof 11